Cargando…
PET Imaging in Huntington’s Disease
To date, little is known about how neurodegeneration and neuroinflammation propagate in Huntington’s disease (HD). Unfortunately, no treatment is available to cure or reverse the progressive decline of function caused by the disease, thus considering HD a fatal disease. Mutation gene carriers typica...
Autores principales: | Roussakis, Andreas-Antonios, Piccini, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927896/ https://www.ncbi.nlm.nih.gov/pubmed/26683130 http://dx.doi.org/10.3233/JHD-150171 |
Ejemplares similares
-
Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2020) -
Brain Imaging and Impulse Control Disorders in Parkinson’s Disease
por: Roussakis, Andreas–Antonios, et al.
Publicado: (2019) -
A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2023) -
Current status of PET imaging in Huntington’s disease
por: Pagano, Gennaro, et al.
Publicado: (2016) -
Dopamine Transporter Density in de novo Parkinson’s Disease Does Not Relate to the Development of Levodopa-Induced Dyskinesias
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2019)